Cargando…

The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis

OBJECTIVE AND DESIGN: It has been demonstrated that changes in the normal-appearing white matter (NAWM) in multiple sclerosis precede the appearance of classical lesions. The understanding of NAWM biology in an established disease model might help to clarify why some of them progress to active demye...

Descripción completa

Detalles Bibliográficos
Autores principales: Kipp, M., Norkus, A., Krauspe, B., Clarner, T., Berger, K., van der Valk, P., Amor, S., Beyer, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SP Birkhäuser Verlag Basel 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125513/
https://www.ncbi.nlm.nih.gov/pubmed/21516513
http://dx.doi.org/10.1007/s00011-011-0339-0
_version_ 1782207229142761472
author Kipp, M.
Norkus, A.
Krauspe, B.
Clarner, T.
Berger, K.
van der Valk, P.
Amor, S.
Beyer, C.
author_facet Kipp, M.
Norkus, A.
Krauspe, B.
Clarner, T.
Berger, K.
van der Valk, P.
Amor, S.
Beyer, C.
author_sort Kipp, M.
collection PubMed
description OBJECTIVE AND DESIGN: It has been demonstrated that changes in the normal-appearing white matter (NAWM) in multiple sclerosis precede the appearance of classical lesions. The understanding of NAWM biology in an established disease model might help to clarify why some of them progress to active demyelinating lesions. MATERIAL OR SUBJECTS: C57BL6 male mice (19–21 g) were used in this study. TREATMENT: Demyelination was induced by feeding mice a diet containing 0.2% cuprizone for up to 5 weeks. METHODS: Routine stainings (luxol fast blue, and hematoxylin and eosin) and immunohistochemistry were performed to assess myelin status and the inflammatory infiltrate. RESULTS: We demonstrated that, in the toxic demyelination cuprizone model, the corpus callosum is severely demyelinated after a 5-week cuprizone challenge (acute demyelination) whereas the fimbria of the hippocampus appear normal in routine myelin stainings. Microgliosis but not astrogliosis is evident after acute demyelination in the fimbria. Interestingly, both regions, the fimbria and the corpus callosum, demonstrated early oligodendrocyte apoptosis as well as intense microglia accumulation and activation. However, only the corpus callosum progresses to actively demyelination lesions whereas the fimbria does not. CONCLUSIONS: The applied model appears suitable for elucidating pathways which promote progression of affected tissue to an active lesion.
format Online
Article
Text
id pubmed-3125513
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher SP Birkhäuser Verlag Basel
record_format MEDLINE/PubMed
spelling pubmed-31255132011-08-09 The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis Kipp, M. Norkus, A. Krauspe, B. Clarner, T. Berger, K. van der Valk, P. Amor, S. Beyer, C. Inflamm Res Short Communication OBJECTIVE AND DESIGN: It has been demonstrated that changes in the normal-appearing white matter (NAWM) in multiple sclerosis precede the appearance of classical lesions. The understanding of NAWM biology in an established disease model might help to clarify why some of them progress to active demyelinating lesions. MATERIAL OR SUBJECTS: C57BL6 male mice (19–21 g) were used in this study. TREATMENT: Demyelination was induced by feeding mice a diet containing 0.2% cuprizone for up to 5 weeks. METHODS: Routine stainings (luxol fast blue, and hematoxylin and eosin) and immunohistochemistry were performed to assess myelin status and the inflammatory infiltrate. RESULTS: We demonstrated that, in the toxic demyelination cuprizone model, the corpus callosum is severely demyelinated after a 5-week cuprizone challenge (acute demyelination) whereas the fimbria of the hippocampus appear normal in routine myelin stainings. Microgliosis but not astrogliosis is evident after acute demyelination in the fimbria. Interestingly, both regions, the fimbria and the corpus callosum, demonstrated early oligodendrocyte apoptosis as well as intense microglia accumulation and activation. However, only the corpus callosum progresses to actively demyelination lesions whereas the fimbria does not. CONCLUSIONS: The applied model appears suitable for elucidating pathways which promote progression of affected tissue to an active lesion. SP Birkhäuser Verlag Basel 2011-04-24 2011 /pmc/articles/PMC3125513/ /pubmed/21516513 http://dx.doi.org/10.1007/s00011-011-0339-0 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Short Communication
Kipp, M.
Norkus, A.
Krauspe, B.
Clarner, T.
Berger, K.
van der Valk, P.
Amor, S.
Beyer, C.
The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis
title The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis
title_full The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis
title_fullStr The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis
title_full_unstemmed The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis
title_short The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis
title_sort hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125513/
https://www.ncbi.nlm.nih.gov/pubmed/21516513
http://dx.doi.org/10.1007/s00011-011-0339-0
work_keys_str_mv AT kippm thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT norkusa thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT krauspeb thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT clarnert thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT bergerk thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT vandervalkp thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT amors thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT beyerc thehippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT kippm hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT norkusa hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT krauspeb hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT clarnert hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT bergerk hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT vandervalkp hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT amors hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis
AT beyerc hippocampalfimbriaofcuprizonetreatedanimalsasastructureforstudyingneuroprotectioninmultiplesclerosis